Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: A critical reappraisal of histomorphological and immunohistochemical criteria for differentiation

Histopathology

Volumn 52, Issue 7, 2008, Pages 865-876

  Costache, M ^a   Bresch, M ^b   Boer A ^b  

^a Clinical Emergency County Hospital Pius Brinzeu Timisoara   (Romania)

^b DERMATOLOGIKUM HAMBURG   (Germany)

Author keywords

Androgen receptors; Cytokeratin 20; Desmoplastic trichaepithelioma; Follicular differentiation; Morpheiform basal cell carcinoma

Indexed keywords

ANDROGEN RECEPTOR; CD34 ANTIBODY; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 20; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BASAL CELL CARCINOMA; BENIGN TUMOR; CALCIFICATION; CANCER MORPHOLOGY; CELL DIFFERENTIATION; CLINICAL ARTICLE; DESMOPLASTIC TRICHOEPITHELIOMA; DIAGNOSTIC ACCURACY; ELASTOSIS; EPITHELIUM TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFUNDIBULUM; MELANOCYTE; MERKEL CELL; NEVUS; OSTEOMA; PATHOLOGIST; PRIORITY JOURNAL; PUNCH BIOPSY; SEBACEOUS CARCINOMA;

EID: 44249087416     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03036.x     Document Type: Article

References (15)

1. 1 Ackerman AB, Böer A. Histopathologic diagnosis of adnexal neoplasms in skin. New York City: Ardor Scribendi, 2007.
2. 2 Brownstein MH, Shapiro L. Desmoplastic trichoepithelioma. Cancer 1977 ; 40 ; 2979–2986.
3. 3 Takei Y. Criteria for histologic differentiation of desmoplastic trichoepithelioma from morphea‐like basal cell carcinoma. Am. J. Dermatopathol. 1985 ; 7 ; 207–221.
4. 4 Ackerman AB, Reddy VB, Soyer P. Neoplasms with follicular differentiation. New York City: Ardor Scribendi, 2001.
5. 5 Abesamis‐Cubillan E, El‐Shabrawi‐Caelen L, LeBoit PE. Merkel cells and sclerosing epithelial neoplasms. Am. J. Dermatopathol. 2000 ; 22 ; 311–315.
6. 6 Kirchmann TT, Prieto VG, Smoller BR. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch. Dermatol. 1994 ; 130 ; 589–592.
7. 7 Pham TT, Selim MA, Burchette JL, Madden J, Turner J, Herman C. CD10 expression in trichoepithelioma and basal cell carcinoma. J. Cutan. Pathol. 2006 ; 33 ; 123–128.
8. 8 Smoller BR, Van de Rijn M, Lebrun D, Warnke RA. bcl‐2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br. J. Dermatol. 1994 ; 131 ; 28.
9. 9 Lum CA, Binder SW. Proliferative characterization of basal‐cell carcinoma and trichoepithelioma in small biopsy specimens. J. Cutan. Pathol. 2004 ; 31 ; 550–554.
10. 10 Verhaegh ME, Arends JW, Majoie IM, Hoekzema R, Neumann HA. Transforming growth factor‐beta and bcl‐2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Dermatol. Surg. 1997 ; 23 ; 695–700.
11. 11 Thewes M, Worret WI, Engst R, Ring J. Stromelysin‐3: a potent marker for differentiation between desmoplastic trichoepihelioma and morphea‐like basal cell carcinoma. Am. J. Dermatopathol. 1998 ; 20 ; 140–142.
12. 12 Izikson L, Bhan A, Zembowicz A. Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumours. Am. J. Dermatopathol. 2005 ; 27 ; 91–95.
13. 13 Basarab T, Orchard G, Russell‐Jones R. The use of immunostaining for bcl2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas. Am. J. Dermatopathol. 1998 ; 20 ; 448.
14. 14 Kurzen H, Esposito L, Langbein L, Hartschuh W. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of basal cell carcinoma and trichoblastoma. Am. J. Dermatopathol. 2001 ; 23 ; 501–509.
15. 15 Jaeschke R, Guyott G, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 1994 ; 271 ; 703.